Your browser doesn't support javascript.
loading
Two independent introductions of SARS-CoV-2 into the Iranian outbreak
Zohreh Fattahi; Marzieh Mohseni; Khadijeh Jalalvand; Fatemeh Aghakhani Moghadam; Azam Ghaziasadi; Fatemeh Keshavarzi; Jila Yavarian; Ali Jafarpour; Seyedeh elham Mortazavi; Fatemeh Ghodratpour; Hanieh Behravan; Mohammad Khazeni; Seyed Amir Momeni; Issa Jahanzad; Abdolvahab Moradi; Alijan Tabarraei; Sadegh Ali Azimi; Ebrahim Kord; Seyed Mohammad Hashemi-Shahri; Azarakhsh Azaran; Farid Yousefi; Zakiye Mokhames; Alireza Soleimani; Shokouh Ghafari; Masood Ziaee; Shahram Habibzadeh; Farhad Jeddi; Azar Hadadi; Alireza Abdollahi; Gholam Abbas Kaydani; Saber Soltani; Talat Mokhtari-Azad; Reza Najafipour; Reza Malekzadeh; Kimia Kahrizi; Seyed Mohammad Jazayeri; Hossein Najmabadi.
Afiliação
  • Zohreh Fattahi; 1. Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. 2. Kariminejad-Najmabadi Pathology & Genetics Center, Tehra
  • Marzieh Mohseni; 1. Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. 2. Kariminejad-Najmabadi Pathology & Genetics Center, Tehra
  • Khadijeh Jalalvand; 1. Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Fatemeh Aghakhani Moghadam; 1. Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Azam Ghaziasadi; 4. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 5. Research Center for Clinical Virology, Tehran Univer
  • Fatemeh Keshavarzi; 1. Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Jila Yavarian; 4. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Ali Jafarpour; 4. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 5. Research Center for Clinical Virology, Tehran Univer
  • Seyedeh elham Mortazavi; 6. Department of Microbiology, Faculty of Biology, College of Science, University of Science & Research, Tehran, Iran.
  • Fatemeh Ghodratpour; 1. Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Hanieh Behravan; 1. Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Mohammad Khazeni; 4. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 7. Booali laboratory, Qom, Iran.
  • Seyed Amir Momeni; 7. Booali laboratory, Qom, Iran.
  • Issa Jahanzad; 8. Pars hospital lab, Rasht, Iran.
  • Abdolvahab Moradi; 9. Infectious Diseases Research Center, Golestan University of Medical Sciences, Golestan, Iran.
  • Alijan Tabarraei; 9. Infectious Diseases Research Center, Golestan University of Medical Sciences, Golestan, Iran.
  • Sadegh Ali Azimi; 9. Infectious Diseases Research Center, Golestan University of Medical Sciences, Golestan, Iran.
  • Ebrahim Kord; 10. Infectious Disease and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Seyed Mohammad Hashemi-Shahri; 10. Infectious Disease and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Azarakhsh Azaran; 11. Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Farid Yousefi; 11. Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Zakiye Mokhames; 12. Department of Molecular Diagnostic, Emam Ali Educational and Therapeutic Center, Alborz University of Medical Sciences, Karaj, Iran.
  • Alireza Soleimani; 12. Department of Molecular Diagnostic, Emam Ali Educational and Therapeutic Center, Alborz University of Medical Sciences, Karaj, Iran.
  • Shokouh Ghafari; 13. Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
  • Masood Ziaee; 13. Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
  • Shahram Habibzadeh; 14. Department of Infectious Disease, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Farhad Jeddi; 14. Department of Infectious Disease, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Azar Hadadi; 15. Department of Infectious Disease, School of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Alireza Abdollahi; 16. Department of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran Iran.
  • Gholam Abbas Kaydani; 17. Department of Laboratory Sciences, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Saber Soltani; 4. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 5. Research Center for Clinical Virology, Tehran Univer
  • Talat Mokhtari-Azad; 4. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Reza Najafipour; 18. Cell and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
  • Reza Malekzadeh; 19. Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Kimia Kahrizi; 1. Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Seyed Mohammad Jazayeri; 4. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 5. Research Center for Clinical Virology, Tehran Univer
  • Hossein Najmabadi; Genetics Research Center, University of Social Welfare & Rehabilitation Sciences
Preprint em En | PREPRINT-MEDRXIV | ID: ppmedrxiv-20229047
ABSTRACT
The SARS-CoV-2 virus has been rapidly spreading globally since December 2019, triggering a pandemic, soon after its emergence, with now more than one million deaths around the world. While Iran was among the first countries confronted with rapid spread of virus in February, no real-time SARS-CoV-2 whole-genome tracking is performed in the country. To address this issue, we provided 50 whole-genome sequences of viral isolates ascertained from different geographical locations in Iran during March-July 2020. The corresponding analysis on origins, transmission dynamics and genetic diversity, represented at least two introductions of the virus into the country, constructing two major clusters defined as B.4 and B.1*. The first entry of the virus occurred around 26 December 2019, as suggested by the time to the most recent common ancestor, followed by a rapid community transmission, led to dominancy of B.4 lineage in early epidemic till the end of June. Gradually, reduction in dominancy of B.4 occurred possibly as a result of other entries of the virus, followed by surge of B.1.* lineages, as of mid-May. Remarkably, variation tracking of the virus indicated the increase in frequency of D614G mutation, along with B.1* lineages, which showed continuity till October 2020. According to possible role of D614G in increased infectivity and transmission of the virus, and considering the current high prevalence of the disease, dominancy of this lineage may push the country into a critical health situation. Therefore, current data warns for considering stronger prohibition strategies preventing the incidence of larger crisis in future.
Licença
cc_by_nc_nd
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Preprint